LON:OBD Oxford BioDynamics - OBD Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 15.25 -1.00 (-6.15%) (As of 03/20/2023 04:05 PM ET) Add Compare Share Share Today's Range 15.11▼ 15.7050-Day Range 13.65▼ 2052-Week Range 10.98▼ 29.50Volume139,891 shsAverage Volume247,655 shsMarket Capitalization£22.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines About Oxford BioDynamics (LON:OBD) StockOxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.Read More Receive OBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address OBD Stock News HeadlinesMarch 12, 2023 | americanbankingnews.comOxford BioDynamics (LON:OBD) Trading Down 3.9%February 10, 2023 | msn.comThis blood test can detect prostate cancer with 94 percent accuracyMarch 20, 2023 | Investing Daily (Ad)27 U.S. Cities Where Stocks Yield 26% a YearWhat’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. February 8, 2023 | msn.comScientists create ‘impressive’ new blood test for prostate cancer that is 94% accurateFebruary 7, 2023 | msn.comNew blood test for prostate cancer is 94% accurate, researchers sayFebruary 2, 2023 | finance.yahoo.comThe Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More SharesJanuary 29, 2023 | finance.yahoo.comOxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)December 19, 2022 | finance.yahoo.comOxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare ConferenceMarch 20, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.December 16, 2022 | finance.yahoo.comMassachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALSOctober 8, 2022 | fool.co.ukOxford BioDynamicsOctober 8, 2022 | finance.yahoo.comOxford BioDynamics (LON:OBD) Will Have To Spend Its Cash WiselyOctober 7, 2022 | marketwatch.comOxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test CommercializationJune 28, 2022 | lse.co.ukOxford BioDynamics shares drop as it might need funding by early 2023June 21, 2022 | barrons.comOxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UKMarch 11, 2022 | finance.yahoo.comOxford BioDynamics Plc (OBD.L)November 22, 2021 | finance.yahoo.comIs Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?October 25, 2021 | marketwatch.comArmistice Capital Invests GBP3.6 Mln in Oxford BioDynamicsAugust 31, 2021 | lse.co.ukGeronimo the alpaca euthanised in Britain despite public outcryAugust 31, 2021 | lse.co.ukTRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory liveAugust 31, 2021 | lse.co.ukRyanair predicts strong recovery, ups passenger targetAugust 31, 2021 | lse.co.ukOxford BioDynamics awarded $0.91m US PACT grantAugust 31, 2021 | finance.yahoo.comOxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test for Improved Prediction of Patient Response to Immune Checkpoint Inhibitor (ICI) Cancer TherapiesJuly 29, 2021 | marketwatch.comGenetic Testing Market is projected to manifest the fastest CAGR of 11.53% through 2027March 31, 2021 | finance.yahoo.comOxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D useMarch 23, 2021 | fool.co.ukThe Oxford BioDynamics share price is up 30% today. Here’s what I’d do nowMarch 23, 2021 | lse.co.ukOxford Biodyn Share News (OBD)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address OBD Company Calendar Last Earnings6/16/2020Today3/20/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:OBD CUSIPN/A CIKN/A Webwww.oxfordbiodynamics.com Phone+44-1865-518910FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-6,710,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-144.60% Return on Assets-40.23% Debt Debt-to-Equity Ratio237.09 Current Ratio0.95 Quick Ratio2.80 Sales & Book Value Annual Sales£176,000.00 Price / Sales127.12 Cash FlowGBX 3.83 per share Price / Cash Flow3.98 Book ValueGBX 3 per share Price / Book5.08Miscellaneous Outstanding Shares146,710,000Free FloatN/AMarket Cap£22.37 million OptionableNot Optionable Beta1.18 Key ExecutivesDr. Jon Anthony Joseph Burrows B.Sc. (Age 59)M.Sc., Ph.D., CEO & Director Comp: $463kMr. Paul Leslie Stockdale F.C.A. (Age 47)M.A., CFO & Director Comp: $202kDr. Alexandre Akoulitchev Ma (Oxon) (Age 60)Ph.D., Chief Scientific Officer & Director Comp: $236kMr. Thomas G. Guiel B.A.Chief Operating OfficerDr. Jayne Green B.Sc.Ph.D., Director of OperationsDr. Ewan Hunter B.Sc.BSC, Ph.D., Ph.D., (KCL), C.D.OT. DemainCompany Sec.Dr. Steven Tucker M.D.FACP, Group Clinical DirectorProf. Siamon GordonClinical Director of Inflammation & InfectionDr. Sandy Primrose Ph.D.Technical ConsultantMore ExecutivesKey CompetitorsHemogenyx PharmaceuticalsLON:HEMOAptamer GroupLON:APTAAorTech InternationalLON:AORSynairgenLON:SNGDestiny PharmaLON:DESTView All CompetitorsInsidersStephen Charles DiggleBought 143,673 shares on 1/26/2023Total: £2.16 M ($15.00/share)Stephen Charles DiggleBought 50,000 shares on 11/11/2022Total: £900,000.00 ($18.00/share)Matthew WakefieldBought 25,000 shares on 5/20/2022Total: £425,000.00 ($17.00/share)Paul StockdaleBought 30,000 shares on 4/6/2022Total: £540,000.00 ($18.00/share)View All Insider Transactions OBD Stock - Frequently Asked Questions How have OBD shares performed in 2023? Oxford BioDynamics' stock was trading at GBX 17.15 on January 1st, 2023. Since then, OBD stock has decreased by 11.1% and is now trading at GBX 15.25. View the best growth stocks for 2023 here. How were Oxford BioDynamics' earnings last quarter? Oxford BioDynamics Plc (LON:OBD) posted its quarterly earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter. What other stocks do shareholders of Oxford BioDynamics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL). What is Oxford BioDynamics' stock symbol? Oxford BioDynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD." How do I buy shares of Oxford BioDynamics? Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Oxford BioDynamics' stock price today? One share of OBD stock can currently be purchased for approximately GBX 15.25. How much money does Oxford BioDynamics make? Oxford BioDynamics (LON:OBD) has a market capitalization of £22.37 million and generates £176,000.00 in revenue each year. The biotechnology company earns £-6,710,000.00 in net income (profit) each year or GBX (0.06) on an earnings per share basis. How can I contact Oxford BioDynamics? Oxford BioDynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The official website for the company is www.oxfordbiodynamics.com. The biotechnology company can be reached via phone at +44-1865-518910. This page (LON:OBD) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.